The shares of Greece-based Genco Shipping & Trading Limited (GNK: sentiment, chart, options) have added nearly 7% in early afternoon trading, bolstered in the wake of a new deal.
Which Greek philosopher do you admire most?
More specifically, the dry bulk diva this morning announced that it inked a $65,000 per day, 46-to-62 month deal with Cargill International S.A. for use of its newly delivered Capesize vessel. As part of the agreement, which includes a 50% index-based sharing component, Genco will pay a third-party brokerage commission of 5%.
The vessel, deemed Genco Hadrian, is the sixth ship delivered under GNK's previously announced agreement to purchase 9 Capsesize vessels. The shipping sultan drew $96.8 million from its $1.4 billion revolving credit facility to purchase Hadrian, and today said that it expects to acquire an additional 3 vessels with the existing credit facility and cash flow from operations. The new purchases are slated for delivery in 2009.
The news, in conjunction with a broad-market boost, has shipped the shares of GNK more than 75 cents higher to hover near the $12.70 level.
From a longer-term perspective, however, the charts aren't as pretty. Since perforating support in the round-number $50 region in September, the security has shed roughly 75%. Further demonstrating the stock's technical troubles of late is its performance versus the broad market. During the past 60 trading sessions, GNK has underperformed the S&P 500 Index (SPX) by about 45%.
The stock is now wrestling with resistance at its 10-week moving average – a trendline that's limited all but a handful of GNK's rally attempts since it peaked near $85 in mid-May.
In light of the security's technical troubles of late, options players are skewed toward the bears' lair. Genco's Schaeffer's put/call open interest ratio (SOIR) – which measures options slated to expire within 3 months – of 0.89 registers in the 96th annual percentile. In other words, short-term options speculators have been more leery of GNK only 4% of the time during the past year.
Meanwhile, in parity with the pessimism in the options pits is the snowballing skepticism in the short-selling arena. During just the past month, short interest on the equity has skyrocketed roughly 49%, and now accounts for about 5.3 million GNK shares, or nearly 21.5% of the shipping sultan's total available float.
However, not everyone has boarded the bearish bandwagon. The shares currently boast an awe-inspiring 6 "strong buys," according to Zacks, compared to a mild 3 "holds" and no "sells."
Furthermore, the average 12-month price target on the underperformer rests at $30.07, Thomson Financial reports. In order to attain this grandiose goal – in a region the stock hasn't closed a session above since September – the shares of GNK would need to more than double from their current trading range.
In conclusion, in order to prove that today's muscle on the charts is more than just a brief vacation in the black, the shares of GNK will need to topple intermediate-term resistance. More specifically, the shipping czar will need to defeat its 10-week trendline, as this moving average has contained most of the stock's rally attempts during the latter half of 2008.
Should the security's current war with resistance prove futile, the remaining GNK enthusiasts among the analyst community could get spooked. A fresh round of downgrades and/or price-target reductions could act as a potential technical storm, amplifying selling pressure on the equity.
Enjoy Sentiment Snapshot? Now, you can get it sent directly to your inbox. Simply click here to sign in, select "author" from the first box, determine how often you'd like to be alerted, and enter "Andrea Kramer" into the third box. Easy as 1, 2, 3!
Discuss this article:
Post your own comment
More articles:
McDonald's Corp (MCD: sentiment, chart, options) is in the news this morning as the company announced a 2.6% increase in January sales at restaurants open at least 13 months. Same-store sales in the closely watched U.S. region fell 0.7%, while those in Europe and in the Asia/Pacific, Middle East and Africa region both rose 4.3%. read more...
Bristol-Myers Squibb (BMY) read more...
Option traders are betting on a continued slump for casino concern Bally Technologies Inc. (BYI: sentiment, chart, options) , despite an upbeat analyst endorsement over the weekend. read more...
Aetna Inc. (AET) read more...
Research In Motion Limited (RIMM: sentiment, chart, options) has attracted an unusual amount of attention from option traders today – especially on the put side of the tape. In early afternoon activity, the BlackBerry maker has seen roughly 17,000 puts change hands, already surpassing the stock's expected single-session volume of about 15,000 puts. read more...
Earnings season is upon us, and investors all across Wall Street are hoping to take advantage of these potentially volatile few weeks. Large bull (and bear) gaps, upgrades and downgrades, and short squeezes all become increasingly more likely during this period, as companies meet, beat, or miss quarterly expectations. As such, it is imperative that traders be well equipped to deal with all of the eventualities. read more...
NRG Energy (NRG) read more...
Bullish call spreads are known by a variety of different names among options traders. But whether the position is a bull call spread, bullish debit spread, or a long vertical call spread, it is still constructed by purchasing an at-the-money or in-the-money call while simultaneously selling an out-of-the-money call. The reasoning behind pairing up these seemingly contradictory options is really quite simple: limited risk. read more...
McDonald's Corp. (MCD) read more...
Amylin Pharmaceuticals Inc. (AMLN: sentiment, chart, options) makes and markets two injectable diabetes drugs, Byetta and Symlin, that are approved as adjunct diabetes therapies, according to Hoover's. The company is working on other diabetes drugs, including a once-weekly version of Byetta, as well as treatments for obesity. read more...
Today's Most Popular Stories